hemostatikum kolagénové vstrebateľné hemopatch
baxter healthcare sa thurgauerstrasse 130 8010 glattpark (opfikon) Švajčiarsko -
kazeta dialyzačná bicart
baxter healthcare sa thurgauerstrasse 130 8010 glattpark (opfikon) Švajčiarsko -
kazeta dialyzačná bicart
baxter healthcare sa thurgauerstrasse 130 8010 glattpark (opfikon) Švajčiarsko -
roztok intraperitoneálny adept
baxter healthcare sa thurgauerstrasse 130 8010 glattpark (opfikon) Švajčiarsko -
súprava urologická irigačná
baxter healthcare sa thurgauerstrasse 130 8010 glattpark (opfikon) Švajčiarsko -
súprava rozprašovača tissel/artiss 1504272
baxter healthcare sa thurgauerstrasse 130 8010 glattpark (opfikon) Švajčiarsko -
kapsula čistiaca bicart select combi-pak
baxter healthcare sa thurgauerstrasse 130 8010 glattpark (opfikon) Švajčiarsko -
koncentrát kyselinový dialyzačný physiopack citrate
baxter healthcare sa thurgauerstrasse 130 8010 glattpark (opfikon) Švajčiarsko -
súprava na mimotelové čistenie krvi a/alebo pri hemoperfúzii oxiris
baxter healthcare sa thurgauerstrasse 130 8010 glattpark (opfikon) Švajčiarsko -
pemetrexed baxter
baxter holding b.v. - pemetrexed disodium heptahydrate - carcinoma, non-small-cell lung; mesothelioma - antineoplastické činidlá - malignant pleural mesotheliomapemetrexed baxter in combination with cisplatin is indicated for the treatment of chemotherapy naïve patients with unresectable malignant pleural mesothelioma. non-small cell lung cancerpemetrexed baxter in combination with cisplatin is indicated for the first line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology (see section 5. pemetrexed baxter is indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology in patients whose disease has not progressed immediately following platinum-based chemotherapy (see section 5. pemetrexed baxter is indicated as monotherapy for the second line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology (see section 5.